Adesso reports 13% sales growth in first half of 2026

adesso reported 1H 2026 sales up 13% YoY and EBITDA up 21% to EUR 45.80m, while maintaining its full-year forecast of sales EUR 1.6–1.7bn and EBITDA EUR 130–150m. The generative AI business boosted order intake and added new client relationships, with profitability improving as staff utilization recovered after a weaker start. The company also agreed to acquire AI claims platform omni:us to strengthen its insurance offering, and expects higher earnings in 2H 2026 on improved utilization and more working days.

Analysis

The incremental signal is margin leverage, not the revenue print. In a labor-heavy services model, a modest recovery in billable utilization can expand EBITDA faster than sales, so the next two quarters matter more than the last one: if utilization holds and working days normalize, consensus likely still underestimates H2 operating leverage. That makes the stock sensitive to any follow-through in bookings, because the market tends to pay up only once it sees revenue quality convert into sustained margin expansion.

The omni:us acquisition is more interesting as a mix-shift signal than as a near-term earnings driver. If adesso can package claims automation into its insurance relationships, it could move from low-multiple staff augmentation toward a stickier, higher-multiple workflow/software hybrid, which would matter over 6-18 months. That is a relative negative for pure-play IT services peers that rely on hours-based delivery and lack a vertical AI wedge, especially other European digital services names exposed to financials and insurance.

The contrarian risk is that part of the second-half optimism may be calendar-driven rather than demand-driven. If clients are still cautious, the market can fade this as a temporary utilization bounce once the working-day tailwind rolls off. The thesis is falsified if the next quarterly update fails to show sustained utilization improvement, if order intake slows outside AI-related deals, or if integration costs from omni:us absorb the expected margin uplift. Time horizon: near-term reaction is days; confirmation window is 1-3 months; structural re-rating would take multiple quarters.

Key Decisions for Investors

• Long ADSGF on pullbacks over the next 1-3 weeks; the setup is a margin-leverage story with ~15-20% upside if H2 guidance confidence improves, but tighten risk if utilization does not stay above the mid-2Q inflection.
• Relative-value pair: long ADSGF / short GFT Technologies (GFT.DE) for 1-3 months. Thesis: adesso has a clearer utilization rebound and a more tangible insurance-AI wedge; cover the short if GFT prints materially stronger financial-services backlog or adesso integration commentary turns cautious.
• If liquidity is poor in ADSGF, use ADS.DE on Frankfurt rather than chasing OTC prints; avoid options unless spreads are tight, because the trade is a fundamental re-rating story, not a volatility event.
• Set a catalyst alert for the next quarterly release: if EBITDA margin does not expand sequentially and management does not sound more confident on H2 bookings, de-rate the long and assume the market has already priced the calendar tailwind.